Phibro Animal Health Financial Ratios
NASDAQ: PAHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Phibro Animal Health ratio analysis
Phibro Animal Health earned a net margin of 6.6% in FY 2026, up from 3.7% a year earlier. Gross margin was 33.8% compared with a median of 32.0% over the prior 9 years. Return on equity reached 25.9%, meaning Phibro Animal Health generated 0.26 dollars of profit for every dollar of shareholders' equity.
At the end of FY 2026, PAHC traded at 13.7 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 13.7 to 279.5, with a median of 23.3. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Phibro Animal Health financial ratios (annual)
| Ratio | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 13.69 | 23.53 | 279.50 | 16.91 | 16.19 | 22.04 | 31.41 | 23.53 | 28.60 | 23.01 |
| Price / sales | 0.89 | 0.88 | 0.67 | 0.57 | 0.84 | 1.43 | 1.32 | 0.00 | 0.00 | 0.00 |
| Price / book | 3.50 | 3.97 | 2.65 | 1.96 | 3.02 | 5.01 | 5.60 | 0.01 | 0.01 | 0.01 |
| Gross margin | 33.8% | 30.9% | 30.8% | 30.5% | 30.3% | 32.6% | 32.1% | 32.0% | 32.5% | 32.5% |
| Operating margin | 12.8% | 8.5% | 5.2% | 7.3% | 8.4% | 9.0% | 8.6% | 10.1% | 12.1% | 12.8% |
| Net margin | 6.6% | 3.7% | 0.2% | 3.3% | 5.2% | 6.5% | 4.2% | 6.6% | 7.9% | 8.5% |
| Free cash flow margin | 0.6% | 3.2% | 4.6% | -3.9% | -0.6% | 2.3% | 3.2% | 2.1% | 6.3% | 10.1% |
| Return on equity (ROE) | 25.9% | 16.9% | 0.9% | 11.5% | 18.7% | 22.8% | 17.8% | 25.3% | 35.1% | 42.7% |
| Return on assets (ROA) | 6.6% | 3.5% | 0.2% | 3.4% | 5.3% | 6.5% | 4.3% | 7.5% | 9.7% | 10.4% |
| Debt / equity | — | 2.21 | 1.22 | 1.18 | 1.10 | 1.28 | 1.26 | 1.07 | 1.31 | 1.64 |
| Current ratio | 2.96 | 2.76 | 2.94 | 3.33 | 2.97 | 3.04 | 2.87 | 3.02 | 2.90 | 3.14 |
| Revenue growth | 17.1% | 27.4% | 4.1% | 3.8% | 13.1% | 4.1% | -3.3% | 1.0% | 7.3% | 1.7% |
| EPS growth | 104.2% | 1,883.3% | -92.6% | -33.1% | -9.7% | 61.4% | -38.5% | -16.1% | 0.0% | -22.2% |